Merkel cell carcinoma of the skin: Imaging and clinical features in 93 cases

被引:59
作者
Eftekhari, F
Wallace, S
Silva, EG
Lenzi, R
机构
[1] UNIV TEXAS,MD ANDERSON CANC CTR,DIV PATHOL,HOUSTON,TX 77030
[2] UNIV TEXAS,MD ANDERSON CANC CTR,DEPT INVEST THERAPY,HOUSTON,TX 77030
关键词
D O I
10.1259/0007-1285-69-819-226
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Clinical, pathological and imaging data for 93 patient with Merkel cell carcinoma were reviewed. Median survival duration from the date of diagnosis was estimated using the Kaplan-Meier product-limit method. Survival durations of patients with no metastastic disease, with regional lymph node metastasis only and with distant metastases were compared using the Cox-Mantel log-rank rest, The median age for patients with Merkel cell carcinoma was 70 years (range 35-91 years) The tumour occurred in 71 men and 22 women. The most common primary site was the head and neck region (64 patients). followed by the extremities (21 patients) and the trunk (10 patients). Median survival duration for the whole group was 33 months (range 2-140 months). Imaging studies of the primary sites were available for 10 patients and of metastatic sites for seven patients. Sonograms of the primary skin lesions showed single or multicentric hypoechoic nodules arising from the dermis and growing into the subcutaneous tissues. CS scans showed single or multiple minimally enhancing soft tissue nodules. in two instances associated with lyric bone erosion. The metastatic lesions were moderately hypoechoic on sonography and target-shaped with or without ring-enhancement on CT. Imaging studies have a limited role in diagnosis of the clinically evident primary skin lesions but ma! be helpful in the assessment of the depth of the invasion and are crucial in the evaluation of regional and distant metastatic disease. If regional adenopathy is found then CT of the cheat. abdomen and pelvis may be in order.
引用
收藏
页码:226 / 233
页数:8
相关论文
共 33 条
[1]   VP-16, CISPLATIN, DOXORUBICIN, AND BLEOMYCIN IN METASTATIC MERKEL CELL-CARCINOMA - REPORT OF A CASE WITH LONG-TERM REMISSION [J].
AZAGURY, M ;
CHEVALLIER, B ;
ATLAN, D ;
GRAIC, Y ;
DAYOT, JP ;
THOMINE, E .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02) :102-104
[2]   ENDOCRINE DIFFERENTIATION IN BASAL-CELL CARCINOMA [J].
EUSEBI, V ;
MAMBELLI, V ;
TISON, V ;
DELELLIS, R ;
BETTS, CM .
TUMORI, 1979, 65 (02) :191-199
[3]  
Featherstone T, 1990, Clin Oncol (R Coll Radiol), V2, P52, DOI 10.1016/S0936-6555(05)80219-5
[4]   THE USE OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN THE TREATMENT OF MERKEL CELL-CARCINOMA [J].
FENIG, E ;
LURIE, H ;
SULKES, A .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (01) :54-57
[5]  
FEUN LG, 1988, CANCER, V62, P683, DOI 10.1002/1097-0142(19880815)62:4<683::AID-CNCR2820620406>3.0.CO
[6]  
2-J
[7]   MERKEL CELL-CARCINOMA OF THE SKIN - THE STRUCTURE AND ORIGIN OF NORMAL MERKEL CELLS [J].
FRIGERIO, B ;
CAPELLA, C ;
EUSEBI, V ;
TENTI, P ;
AZZOPARDI, JG .
HISTOPATHOLOGY, 1983, 7 (02) :229-249
[8]  
GEHAN EA, 1965, BIOMETRIKA, V52, P650, DOI 10.2307/2333721
[9]  
GOEPFERT H, 1984, ARCH OTOLARYNGOL, V110, P707
[10]   NEURO-ENDOCRINE (MERKEL CELL) CARCINOMA OF THE SKIN - ITS NATURAL-HISTORY, DIAGNOSIS, AND TREATMENT [J].
HITCHCOCK, CL ;
BLAND, KI ;
LANEY, RG ;
FRANZINI, D ;
HARRIS, B ;
COPELAND, EM .
ANNALS OF SURGERY, 1988, 207 (02) :201-207